Transcranial Magnetic Stimulation (TMS) for Thoracic Surgery
WithdrawnNot applicableNCT03994991
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients with high severity of post-surgical pain scores will be randomized to transcranial magnetic stimulation (TMS) vs sham TMS groups. Both group of patients will have 10 TMS sessions during 5 days. Our hypothesis is that, the reduction in the severity of pain scores will be greater among those patients who are randomized to active TMS group compared to sham TMS group. The investigators will explore how improvements in pain correlate with changes in brain network connectivity.
Study details
- Official title
- Personalized Neuromodulation for Treating Post-surgical Pain
- Conditions
- Thoracic Surgery
- Chronic Pain
- Transcranial Magnetic Stimulation
- Neuromodulation
- Interventions
- Device: active TMS
- Device: sham TMS
- Sponsor
- Emine Bayman
- Organization
- University of Iowa
- Start date
- 2021-02-01
- Primary completion
- 2021-05-19
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * English speaking * 18 to 80 years old * scheduled thoracic surgery w/one of the following procedures: thoracotomy, pneumonectomy, removal of lung other than bilobectomy, pneumonectomy, completion pneumonectomy, sleeve lobectomy, segmentectomy, single or multiple wedge resection, or thoracoscopy with excision-plication of bullae, with lobectomy, with partial or total pulmonary decortication or with wedge resection of lung. * Post-surgery pain equal or greater 4 at phone screen Exclusion Criteria: * limitations of self-expression or visual dysfunction (as assessed by research team member during inpatient screen) * having emergency surgery * bipolar, schizophrenia or other psychotic disorders * Alzheimer's, dementia, epilepsy, traumatic brain injury or other similarly impacting neurological issues * pregnancy * incarceration * pain in thoracic region for last two or more months * additional MRI/TMS exclusions: (implants, stents, neurostimulators, metal, claustrophobia, certain medications)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03994991